Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research

Scarred Uterus Clinical Trial

Official title: Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research

Status Not yet recruiting

Clinical Trial Summary

As the "two-child" policy implementation, caesarean women's clinical pregnancy is a huge problem again, Especially the placenta planting abnormal disease is a serious threat to the maternal health and life. Through this research, the investigators can obtain relevant epidemiological data and provide objective data for the department of public health policy; Predicting an placenta abnormal planting early diagnosis model was constructed, it will fill the blank in this field, and high-risk groups in the early stages of pregnancy will be taken proper disposal, the related complications will be reduced to ensure the safety of maternal.

Clinical Trial Description

This study focus on four hands: (1) to investigate different types of gestational sac implantation for pregnancy in caesarean women of childbearing age;(2) to explore the relationship between abnormal placenta planting disease in middle-late pregnancy and the different types of scar pregnancy (3) to explore the the value of ultrasound and serological markers for early diagnosis of placenta planting disease from scar pregnancy; (4) to compare the end and the influence of health economy of different termination method on scar pregnancy. ;

Related Conditions & MeSH terms

• Scarred Uterus

• NCT number: NCT02946749
• Study type: Observational
• Source: Shanghai First Maternity and Infant Hospital
• Contact: Hao Ying, PHD
• Phone: 13371985049
• Email: stephenying2011@126.com
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 2016
• Completion date: December 2018